BIOMAT Database Logo BIOMAT Database Logo

1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands. 2007

Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Johnson & Johnson Pharmaceutical Research and Development LLC, Drug Discovery Research, PO Box 300, 1000 Route 202 South, Raritan, NJ 08869, USA. sli3@prdus.jnj.com

Subtype-selective alpha-1a and/or alpha-1d adrenergic receptor antagonists may be useful for the treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with fewer adverse effects than non-selective drugs. A series of 1-arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones has been synthesized, displaying in vitro alpha(1a) and alpha(1d) binding affinity K(i) values in the range of 0.09-38nM with K(i)(alpha1b)/K(i)(alpha1a) and K(i)(alpha1b)/K(i)(alpha1d) selectivity ratios up to 3607-fold.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D044024 Tetralones A group of TETRAHYDRONAPHTHALENES containing a keto oxygen.

Related Publications

Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.
July 2001, Bioorganic & medicinal chemistry letters,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
July 1995, The Journal of pharmacology and experimental therapeutics,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones.
January 2007, Bioorganic & medicinal chemistry letters,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.
August 2000, Bioorganic & medicinal chemistry letters,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.
January 1999, Bioorganic & medicinal chemistry letters,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
April 2009, Journal of medicinal chemistry,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
June 2008, Journal of medicinal chemistry,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
April 2004, Journal of medicinal chemistry,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.
May 1986, Journal of medicinal chemistry,
Shengjian Li, and George Chiu, and Virginia L Pulito, and Jingchun Liu, and Peter J Connolly, and Steven A Middleton
N-substituted-3-arylpyrrolidines: potent and selective ligands at serotonin 1A receptor.
May 1999, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!